Katherine McNamara
4PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 30, 2021
Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response.Katherine L McNamara, Jennifer L Caswell-Jin, Rohan Joshi
|Nov 18, 2020
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07).Sara A Hurvitz, Jennifer L Caswell-Jin, Katherine L McNamara
|Jun 01, 2019
Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.Jennifer L Caswell-Jin, Katherine McNamara, Johannes G Reiter
|Feb 10, 2019
Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.Jennifer L Caswell-Jin, Katherine McNamara, Johannes G Reiter
Pageof 1
Frequent Collaborators
4 joint publications
Jennifer L Caswell-Jin
4 joint publications
Christina Curtis
2 joint publications
Gregory R Bean
2 joint publications
Debu Tripathy
2 joint publications
Johannes G Reiter
2 joint publications
Ruping Sun
2 joint publications
Suet-Feung Chin
2 joint publications
Carlos Caldas
2 joint publications
Julie Lang
1 joint publications
Joan S Brugge
